Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $22.60 Analyst target: $38.67 Upside: 71.11%
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. The company is headquartered in Los Altos, California.
See the full interactive analysis & chart →Informational only — not investment advice.